Latest News for: hazard ratio

Edit

New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference

Pharmiweb 19 Mar 2025
... reduced risk of death by 92–94% (hazard ratio=0.06–0.08; p<0.0001) and 87–95% (hazard ratio=0.05–0.13; p<0.0001) in the time from symptom onset and starting treatment, respectively.3&nbsp;.
Edit

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

Canoe 09 Mar 2025
Story continues below ... Article content ... Travel Time ... Sign Up ... Among participants who switched to an integrase inhibitor-based regimen compared to those who did not, researchers estimated an increased risk of developing obesity [hazard ratio (HR) ... .
Edit

5 under-the-radar UK shares that deserve more attention

The Motley Fool 05 Mar 2025
However, I believe this potential hazard is baked into the bank’s low price-to-earnings (P/E) ratio of 5.2 times ... Yu is exposed to big swings in commodity prices, customer bad debt and the financial hazards of fixed price contracts.
Edit

Depemokimab delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polyps (CRSwNP)

Pharmiweb 03 Mar 2025
... and 64% (n=164) patients in the placebo arm did not have intervention with SCS, surgery, or disease modulating medication (odds ratio [95% CI] ... 83% (n=213) in the placebo group (hazard ratio [95% CI].
Edit

Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer

Pharmiweb 03 Mar 2025
... chemotherapy alone in patients treated with the&nbsp;Imfinzi-based perioperative regimen (32% data maturity; EFS hazard ratio [HR] 0.68; 95% confidence interval [CI] 0.53-0.88; p=0.003902).
  • 1
×